|
Market Closed -
Nasdaq
21:00:00 16/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 55.31 USD | -2.69% |
|
-4.27% | +39.81% |
| 11-09 | AtriCure, Inc. Presents at 2026 UBS Global Healthcare Conference, Nov-09-2026 11:00 AM | |
| 11-05 | Atricure Insider Sold Shares Worth $546,260, According to a Recent SEC Filing | MT |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 2,817 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | 43.2% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 2,649 | 2,588 | 2,491 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | 41.44% | -2.31% | -3.74% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 212x | 119x | 78.2x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 4.88x | 4.33x | 3.78x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -1x | 1.5x | 1.5x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 4.63x | 4.13x | 3.67x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 4.35x | 3.79x | 3.24x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 28.8x | 24.8x | 19.8x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 155x | 91.3x | 56.3x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 48.4x | 63.7x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 2.07% | 1.57% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.2606 | 0.4662 | 0.7071 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 608.3 | 682.3 | 767.8 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 91.99 | 104.5 | 126.1 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 17.12 | 28.33 | 44.26 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 13.08 | 23.5 | 36.07 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -167.7 | -229 | -325.9 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 55.31 | 55.31 | 55.31 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,922 | - | - |
| Announcement Date | 15/02/22 | 21/02/23 | 15/02/24 | 12/02/25 | 17/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 218.1x | 4.48x | 29.64x | -.--% | 2.89B | ||
| 35.9x | 4.23x | 15.9x | 2.39% | 188B | ||
| 22.27x | 3.77x | 13.5x | 2.76% | 126B | ||
| 26.7x | 4.76x | 16.31x | 1.16% | 118B | ||
| 32x | 3.08x | 12.43x | 2.23% | 92.48B | ||
| 19.04x | 0.23x | 14.13x | 0.66% | 68.51B | ||
| 44.44x | 3.9x | 13.29x | 1.92% | 59.39B | ||
| 46.74x | 11.74x | 32.93x | -.--% | 55.48B | ||
| 28.66x | 7.1x | 18x | 1.4% | 49.62B | ||
| 45.81x | 3.44x | 12.72x | 0.5% | 35.17B | ||
| Average | 51.97x | 4.67x | 17.89x | 1.3% | 80B | |
| Weighted average by Cap. | 32.52x | 4.40x | 16.06x | 1.74% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
















